296 related articles for article (PubMed ID: 10439042)
41. Inducible short-term and stable long-term cell culture systems reveal that the PAX3-FKHR fusion oncoprotein regulates CXCR4, PAX3, and PAX7 expression.
Tomescu O; Xia SJ; Strezlecki D; Bennicelli JL; Ginsberg J; Pawel B; Barr FG
Lab Invest; 2004 Aug; 84(8):1060-70. PubMed ID: 15184910
[TBL] [Abstract][Full Text] [Related]
42. Lack of effective T-lymphocyte response to the PAX3/FKHR translocation area in alveolar rhabdomyosarcoma.
Rodeberg DA; Nuss RA; Heppelmann CJ; Celis E
Cancer Immunol Immunother; 2005 Jun; 54(6):526-34. PubMed ID: 15838707
[TBL] [Abstract][Full Text] [Related]
43. Structural characterization of the FKHR gene and its rearrangement in alveolar rhabdomyosarcoma.
Davis RJ; Bennicelli JL; Macina RA; Nycum LM; Biegel JA; Barr FG
Hum Mol Genet; 1995 Dec; 4(12):2355-62. PubMed ID: 8634710
[TBL] [Abstract][Full Text] [Related]
44. Transcriptional regulation of IGF-I receptor gene expression by the PAX3-FKHR oncoprotein.
Ayalon D; Glaser T; Werner H
Growth Horm IGF Res; 2001 Oct; 11(5):289-97. PubMed ID: 11735247
[TBL] [Abstract][Full Text] [Related]
45. The hybrid PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma transforms fibroblasts in culture.
Scheidler S; Fredericks WJ; Rauscher FJ; Barr FG; Vogt PK
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9805-9. PubMed ID: 8790412
[TBL] [Abstract][Full Text] [Related]
46. Embryonic expression of the tumor-associated PAX3-FKHR fusion protein interferes with the developmental functions of Pax3.
Anderson MJ; Shelton GD; Cavenee WK; Arden KC
Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1589-94. PubMed ID: 11171995
[TBL] [Abstract][Full Text] [Related]
47. Pax7-FKHR transcriptional activity is enhanced by transcriptionally repressed MyoD.
Olguín HC; Patzlaff NE; Olwin BB
J Cell Biochem; 2011 May; 112(5):1410-7. PubMed ID: 21321994
[TBL] [Abstract][Full Text] [Related]
48. The COOH-terminal transactivation domain plays a key role in regulating the in vitro and in vivo function of Pax3 homeodomain.
Cao Y; Wang C
J Biol Chem; 2000 Mar; 275(13):9854-62. PubMed ID: 10734141
[TBL] [Abstract][Full Text] [Related]
49. Normal and rearranged PAX3 expression in human rhabdomyosarcoma.
Frascella E; Toffolatti L; Rosolen A
Cancer Genet Cytogenet; 1998 Apr; 102(2):104-9. PubMed ID: 9546061
[TBL] [Abstract][Full Text] [Related]
50. Identification of target genes regulated by PAX3 and PAX3-FKHR in embryogenesis and alveolar rhabdomyosarcoma.
Barber TD; Barber MC; Tomescu O; Barr FG; Ruben S; Friedman TB
Genomics; 2002 Mar; 79(3):278-84. PubMed ID: 11863357
[TBL] [Abstract][Full Text] [Related]
51. Predominant expression of alternative PAX3 and PAX7 forms in myogenic and neural tumor cell lines.
Barr FG; Fitzgerald JC; Ginsberg JP; Vanella ML; Davis RJ; Bennicelli JL
Cancer Res; 1999 Nov; 59(21):5443-8. PubMed ID: 10554014
[TBL] [Abstract][Full Text] [Related]
52. Variation in the methylation profile and structure of Pax3 and Pax7 among different mouse strains and during expression.
Kay PH; Harmon D; Fletcher S; Ziman M; Jacobsen PF; Papadimitriou JM
Gene; 1997 Jan; 184(1):45-53. PubMed ID: 9016952
[TBL] [Abstract][Full Text] [Related]
53. cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene.
Khan J; Bittner ML; Saal LH; Teichmann U; Azorsa DO; Gooden GC; Pavan WJ; Trent JM; Meltzer PS
Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13264-9. PubMed ID: 10557309
[TBL] [Abstract][Full Text] [Related]
54. [Expression of fusion gene PAX3/PAX7-FKHR and chromosomal aberration in rhabdomyosarcoma].
Gao H; Ou YL; Zhang KR; Zhang ZB; Wang WL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):42-7. PubMed ID: 17285543
[TBL] [Abstract][Full Text] [Related]
55. Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1.
Wachtel M; Dettling M; Koscielniak E; Stegmaier S; Treuner J; Simon-Klingenstein K; Bühlmann P; Niggli FK; Schäfer BW
Cancer Res; 2004 Aug; 64(16):5539-45. PubMed ID: 15313887
[TBL] [Abstract][Full Text] [Related]
56. Mouse mesenchymal stem cells expressing PAX-FKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations.
Ren YX; Finckenstein FG; Abdueva DA; Shahbazian V; Chung B; Weinberg KI; Triche TJ; Shimada H; Anderson MJ
Cancer Res; 2008 Aug; 68(16):6587-97. PubMed ID: 18701482
[TBL] [Abstract][Full Text] [Related]
57. Tumor-specific PAX3-FKHR transcription factor, but not PAX3, activates the platelet-derived growth factor alpha receptor.
Epstein JA; Song B; Lakkis M; Wang C
Mol Cell Biol; 1998 Jul; 18(7):4118-30. PubMed ID: 9632796
[TBL] [Abstract][Full Text] [Related]
58. Pax3-FKHR knock-in mice show developmental aberrations but do not develop tumors.
Lagutina I; Conway SJ; Sublett J; Grosveld GC
Mol Cell Biol; 2002 Oct; 22(20):7204-16. PubMed ID: 12242297
[TBL] [Abstract][Full Text] [Related]
59. PAX--FKHR fusion genes and AChR-gamma in Chinese patients with rhabdomyosarcoma: diagnosis using formalin-fixed archival tissues.
Chang B; Pang LJ; Qi Y; Liu CX; Cao Y; Li HA; Hu WH; Jiang JF; Zhang WJ; Li F
Int J Surg Pathol; 2009 Feb; 17(1):6-15. PubMed ID: 18988640
[TBL] [Abstract][Full Text] [Related]
60. Transgenic mice expressing PAX3-FKHR have multiple defects in muscle development, including ectopic skeletal myogenesis in the developing neural tube.
Finckenstein FG; Davicioni E; Osborn KG; Cavenee WK; Arden KC; Anderson MJ
Transgenic Res; 2006 Oct; 15(5):595-614. PubMed ID: 16952014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
